ME Therapeutics Holdings Inc. (FRA:Q9T)
2.000
+1.130 (129.89%)
At close: Oct 8, 2026
| Market Cap | 20.41M -81.0% |
| Revenue (ttm) | n/a |
| Net Income | -857.38K |
| EPS | -0.03 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 250 |
| Open | 0.875 |
| Previous Close | 0.870 |
| Day's Range | 0.875 - 2.000 |
| 52-Week Range | 0.855 - 3.000 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 27, 2026 |